Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00367445 · ClinicalTrials.gov registry record · Phase 4
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00367445 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 30 participants.
The verdict
NCT00367445, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
Interventions
- DRUG Inhaled Human Insulin (Exubera)
- DRUG Insulin Glargine (Lantus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00367445
The ClinicalTrials.gov registry entry for NCT00367445 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Inhaled Human Insulin (Exubera) is the first listed.
NCT00367445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00367445 about?
NCT00367445 is a clinical study titled "A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus". To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus
What is the current status of trial NCT00367445?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2006-09. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00367445?
The interventions under investigation include: Inhaled Human Insulin (Exubera) (DRUG), Insulin Glargine (Lantus) (DRUG).
Who is sponsoring clinical trial NCT00367445?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.